|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Deferred offering costs | ||||
| Long-term prepaid insurance | ||||
| Investments held in Trust Account | ||||
| Total assets | ||||
| LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT | ||||
| Liabilities | ||||
| Current liabilities: | ||||
| Accrued expenses | ||||
| Accrued offering costs | ||||
| Accounts payable and accrued expenses | ||||
| Related party loan | ||||
| Total current liabilities | ||||
| Deferred legal fees | ||||
| Deferred advisory fee | ||||
| Deferred underwriting fee | ||||
| Total liabilities | ||||
| Temporary equity: | ||||
| Class A ordinary shares subject to possible redemption, 28,750,000 shares at redemption value of $10.23 per share at June 30, 2026 and $10.05 per share at December 31, 2025 | ||||
| Shareholders’ Deficit | ||||
| Ordinary shares, value | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total shareholders’ deficit | ||||
| Total liabilities, temporary equity and shareholders’ deficit |
Loading...
